Panel Endorses Atritech Watchman Stroke-Prevention Device In Close Vote
This article was originally published in The Gray Sheet
Executive Summary
An FDA advisory committee narrowly elected to recommend approval of Atritech's Watchman minimally invasive stroke-prevention device for atrial fibrillation patients, overcoming doubts about the size of the device's pivotal trial